Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
PLoS One ; 18(3): e0282598, 2023.
Article in English | MEDLINE | ID: covidwho-2258705

ABSTRACT

As a branch of the two-dimensional (2D) optimal blanking problem, rectangular strip packing is a typical non-deterministic polynomial (NP-hard) problem. The classical packing solution method relies on heuristic and metaheuristic algorithms. Usually, it needs to be designed with manual decisions to guide the solution, resulting in a small solution scale, weak generalization, and low solution efficiency. Inspired by deep learning and reinforcement learning, combined with the characteristics of rectangular piece packing, a novel algorithm based on deep reinforcement learning is proposed in this work to solve the rectangular strip packing problem. The pointer network with an encoder and decoder structure is taken as the basic network for the deep reinforcement learning algorithm. A model-free reinforcement learning algorithm is designed to train network parameters to optimize the packing sequence. This design can not only avoid designing heuristic rules separately for different problems but also use the deep networks with self-learning characteristics to solve different instances more widely. At the same time, a piece positioning algorithm based on the maximum rectangles bottom-left (Maxrects-BL) is designed to determine the placement position of pieces on the plate and calculate model rewards and packing parameters. Finally, instances are used to analyze the optimization effect of the algorithm. The experimental results show that the proposed algorithm can produce three better and five comparable results compared with some classical heuristic algorithms. In addition, the calculation time of the proposed algorithm is less than 1 second in all test instances, which shows a good generalization, solution efficiency, and practical application potential.


Subject(s)
Algorithms , Reinforcement, Psychology , Reward , Heuristics
2.
Front Immunol ; 13: 938322, 2022.
Article in English | MEDLINE | ID: covidwho-2043444

ABSTRACT

Background: Despite the likely association between coronavirus 2019 (COVID-19) mRNA vaccines and cases of myocarditis/pericarditis, the benefit-risk assessment by the Centers for Disease Control (CDC) still showed a favorable balance for the primary series of COVID-19 mRNA vaccinations. Since August 2021, a full-scale booster vaccination in certain recipients has been recommended. Great concerns about whether the COVID-19 mRNA booster vaccination could increase the risks of myocarditis/pericarditis have been raised since then. The present study aimed to compare the incidence rates and risks of myocarditis/pericarditis between booster and primary vaccination programs. Methods: The CDC COVID Data Tracker and the Vaccines Adverse Event Reporting System (VAERS) were queried between December 11, 2020 and March 15, 2022. Incidence rates were calculated by cases of myocarditis/pericarditis divided by the number of vaccinated people or the total doses of COVID-19 mRNA vaccines. Disproportionality patterns for myocarditis/pericarditis of different COVID-19 mRNA vaccinations were accessed based on the reporting odds and proportional reporting ratios (ROR and PRR, respectively). Results: A total of 2,588 reports of myocarditis/pericarditis were identified after administration of primary-series COVID-19 mRNA vaccination and 269 after the booster dose program during the study period. The incidence of myocarditis/pericarditis following booster COVID-19 mRNA vaccination was lower than that of primary series. The results showed significantly high reporting of myocarditis/pericarditis following the administration of primary COVID-19 mRNA vaccination, whereas the disproportional level was lower in the booster-dose vaccination. Conclusion: This study found that the booster dose of COVID-19 mRNA vaccination when compared with primary series course did not lead to an increase in the risks of myocarditis/pericarditis.


Subject(s)
COVID-19 Vaccines , COVID-19 , Myocarditis , Pericarditis , 2019-nCoV Vaccine mRNA-1273 , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Immunization, Secondary , Myocarditis/epidemiology , Myocarditis/etiology , Pericarditis/epidemiology , Pericarditis/etiology , RNA, Messenger/genetics , Vaccination , Vaccines, Synthetic
3.
Biomed Res Int ; 2022: 3510423, 2022.
Article in English | MEDLINE | ID: covidwho-2020494

ABSTRACT

Purpose: Aurantiamide acetate (AA) is a dipeptide derivative with complex pharmacological activities and remarkable effects on preventing and treating various diseases. In the current study, we aimed to investigate whether AA can exert protective effects in a mouse model of ALI induced by LPS. Materials and Methods: In this model, mice were given intranasal LPS for 3 days prior to receiving AA (2.5, 5, and 10 mg/kg) via oral gavage. An assessment of histopathological changes was performed by hematoxylin and eosin (HE). Proinflammatory cytokines were detected in bronchoalveolar lavage fluids (BALFs) by enzyme-linked immunosorbent assays (ELISAs). The effects of AA on protein expression of NF-κB and PI3K/AKT signaling pathways were determined by Western blot. In addition, lung wet/dry (W/D) weight ratio, myeloperoxidase (MPO) activity, cell counts, and protein content were also measured. Results: According to results, AA pretreatment significantly reduced lung pathological changes, W/D ratio, MPO activity, and protein content. Additionally, AA resulted in a significant reduction in the number of total cells, neutrophils, and proinflammatory cytokines in the BALF after LPS stimulation. The subsequent study revealed that pretreatment with AA dose dependently suppressed LPS-induced activation of NF-κB as well as PI3K/AKT phosphorylation. Conclusion: The results indicated that the AA had a protective effect on LPS-induced ALI in mice and could be a potential drug for ALI.


Subject(s)
Acute Lung Injury , Pneumonia , Acute Lung Injury/chemically induced , Acute Lung Injury/drug therapy , Acute Lung Injury/metabolism , Animals , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/metabolism , Dipeptides/pharmacology , Lipopolysaccharides/adverse effects , Lung/pathology , Mice , Mice, Inbred BALB C , NF-kappa B/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Pneumonia/pathology , Proto-Oncogene Proteins c-akt/metabolism
4.
Journal of Analytical and Applied Pyrolysis ; 167:105677, 2022.
Article in English | ScienceDirect | ID: covidwho-2004167

ABSTRACT

In the context of the COVID-19, the co-pyrolysis of waste cotton swabs and non-woven masks is a promising way of biomass utilization. On the one hand, it alleviates the energy crisis to some extent, and on the other hand, it is conducive to the proper disposal of medical waste. In this paper, the pyrolysis process and kinetic behavior of two materials under different conditions including mixing ratios, heating rates and catalyst additions were studied. The results show that the heating rate has little effect on the pyrolysis process. Mask has better pyrolysis performance than cotton swabs and could promote the decomposition of biomass as an auxiliary material. All the blends show a certain synergistic effect. The difference between the actual mass loss and the theoretical mass loss (ΔW) is positive and the activation energy is lower than that of any single component. The addition of catalyst can further promote the pyrolysis reaction, and the residual mass is greatly reduced. This paper aims to provide some suggestions for further exploration in related fields.

5.
Front Public Health ; 10: 961726, 2022.
Article in English | MEDLINE | ID: covidwho-1974697

ABSTRACT

The construction industry is labor-intensive, and employees' mental health has a significant impact on occupational health and job performance. In particular, expatriates in international projects under the normalization of the epidemic are under greater pressure than domestic project employees. This paper aims to explore the association of stressors and mental health in international constructions during COVID-19. Furthermore, test the mediation effect of psychological resilience and moderating effort of international experience in this relationship. A survey of 3,091 expatriates in international construction projects was conducted. A moderating mediation model was employed to test the effect of psychological resilience and international experience. Then, statistical analysis with a bootstrap sample was used to test the mediation effect of the model, and a simple slope was used to test the moderating effect. Moderated by experience, the slope of the effect of stressors on psychological resilience changed from -1.851 to -1.323. And the slope of the effect of psychological resilience on mental health outcomes reduced by about 0.1. This suggests that experience is one of the buffering factors for individual psychological resilience of expatriates to regulate stress. Theoretically, this study verifies the mediation effect of psychological resilience between COVID-19 related stressors and mental health outcomes and importance of an expatriate's experience in an international assignment. Practically, this study provides guidelines for international construction enterprises and managers to make an assistant plan for expatriates during this pandemic time and pay more attention to their psychological status. The research also suggests that the best choice for challenging assignments is choosing a more experienced employee.


Subject(s)
COVID-19 , Resilience, Psychological , COVID-19/epidemiology , Humans , Outcome Assessment, Health Care , Pandemics , Stress, Psychological/epidemiology
6.
Fractal and Fractional ; 6(5):232, 2022.
Article in English | ProQuest Central | ID: covidwho-1871288

ABSTRACT

With outbreaks of epidemics, an enormous loss of life and property has been caused. Based on the influence of disease transmission and information propagation on the transmission characteristics of infectious diseases, in this paper, a fractional-order SIR epidemic model is put forward on a two-layer weighted network. The local stability of the disease-free equilibrium is investigated. Moreover, a conclusion is obtained that there is no endemic equilibrium. Since the elderly and the children have fewer social tiers, a targeted immunity control that is based on age structure is proposed. Finally, an example is presented to demonstrate the effectiveness of the theoretical results. These studies contribute to a more comprehensive understanding of the epidemic transmission mechanism and play a positive guiding role in the prevention and control of some epidemics.

7.
PLoS One ; 16(7): e0255229, 2021.
Article in English | MEDLINE | ID: covidwho-1327982

ABSTRACT

This study is to assess the influences of climate, socio-economic determinants, and spatial distance on the confirmed cases and deaths in the raise phase of COVID-19 in China. The positive confirmed cases and deaths of COVID-19 over the population size of 100,000 over every 5 consecutive days (the CCOPSPTT and DOPSPTT for short, respectively) covered from 25th January to 29th February, 2020 in five city types (i.e., small-, medium-, large-, very large- and super large-sized cities), along with the data of climate, socio-economic determinants, spatial distance of the target city to Wuhan city (DW, for short), and spatial distance between the target city and their local province capital city (DLPC, for short) were collected from the official websites of China. Then the above-mentioned influencing factors on CCOPSPTT and DOPSPTT were analyzed separately in Hubei and other provinces. The results showed that CCOPSPTT and DOPSPTT were significantly different among five city types outside Hubei province (p < 0.05), but not obviously different in Hubei province (p > 0.05). The CCOPSPTT had significant correlation with socio-economic determinants (GDP and population), DW, climate and time after the outbreak of COVID-19 outside Hubei province (p < 0.05), while was only significantly related with GDP in Hubei province (p < 0.05). The DOPSPTT showed significant correlation with socio-economic determinants, DW, time and CCOPSPTT outside Hubei province (p < 0.05), while was significantly correlated with GDP and CCOPSPTT in Hubei province (p < 0.05). Compared with other factors, socio-economic determinants have the largest relative contribution to variance of CCOPSPTT in all studied cities (> 78%). The difference of DOPSPTT among cities was mainly affected by CCOPSPTT. Our results showed that influences of city types on the confirmed cases and death differed between Hubei and other provinces. Socio-economic determinants, especially GDP, have higher impact on the change of COVID-19 transmission compared with other factors.


Subject(s)
COVID-19/epidemiology , Climate , Socioeconomic Factors , COVID-19/mortality , China/epidemiology , Cities/epidemiology , Disease Outbreaks , Humans , Spatial Analysis
8.
Front Pharmacol ; 11: 560209, 2020.
Article in English | MEDLINE | ID: covidwho-843841

ABSTRACT

OBJECTIVE: Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan City, China, coronavirus disease 2019 (COVID-19) has become a global pandemic. However, no special therapeutic drugs have been identified for COVID-19. The aim of this study was to search for drugs to effectively treat COVID-19. MATERIALS AND METHODS: We conducted a retrospective cohort study with a total of 162 adult inpatients (≥18 years old) from Ruijin Hospital (Shanghai, China) and Tongji Hospital (Wuhan, China) between January 27, 2020, and March 10, 2020. The enrolled COVID-19 patients were first divided into the Lianhuaqingwen (LHQW) monotherapy group and the LHQW + Arbidol combination therapy group. Then, these two groups were further classified into moderate and severe groups according to the clinical classification of COVID-19. RESULTS: The early combined usage of LHQW and Arbidol can significantly accelerate the recovery of patients with moderate COVID-19 by reducing the time to conversion to nucleic acid negativity, the time to chest CT improvement, and the length of hospital stay. However, no benefit was observed in severe COVID-19 patients treated with the combination of LHQW + Arbidol. In this study, both Arbidol and LHQW were well tolerated without serious drug-associated adverse events. CONCLUSION: The early combined usage of LHQW and Arbidol may accelerate recovery and improve the prognosis of patients with moderate COVID-19.

SELECTION OF CITATIONS
SEARCH DETAIL